BACKGROUND: Significant controversy has emerged concerning pediatric anxiety disorders. Some researchers question the justification for diagnosing and treating pediatric anxiety disorders, owing to concerns about the inappropriate medicalization of social problems. Others note the importance of diagnosis and treatment, given that pediatric anxiety disorders represent a strong risk factor for serious adult mental disorders. We examine the neural correlates of pediatric anxiety disorders, to consider the validity of the categorization scheme used in recent treatment studies. METHODS: Using inclusion criteria derived from recent treatment trials, we compared gray matter volume throughout the brain in children with and without anxiety. Morphometric analyses used optimized voxel-based morphometry, an automated method for examining structural changes throughout the brain. RESULTS: Reductions in left amygdala gray matter volume were noted for patients with anxiety disorders relative to comparison subjects. CONCLUSIONS: We discuss implications of these findings for current controversies.
BACKGROUND: Significant controversy has emerged concerning pediatric anxiety disorders. Some researchers question the justification for diagnosing and treating pediatric anxiety disorders, owing to concerns about the inappropriate medicalization of social problems. Others note the importance of diagnosis and treatment, given that pediatric anxiety disorders represent a strong risk factor for serious adult mental disorders. We examine the neural correlates of pediatric anxiety disorders, to consider the validity of the categorization scheme used in recent treatment studies. METHODS: Using inclusion criteria derived from recent treatment trials, we compared gray matter volume throughout the brain in children with and without anxiety. Morphometric analyses used optimized voxel-based morphometry, an automated method for examining structural changes throughout the brain. RESULTS: Reductions in left amygdala gray matter volume were noted for patients with anxiety disorders relative to comparison subjects. CONCLUSIONS: We discuss implications of these findings for current controversies.
Authors: Jens Foell; Isabella M Palumbo; James R Yancey; Nathalie Vizueta; Traute Demirakca; Christopher J Patrick Journal: Neuroimage Date: 2018-10-28 Impact factor: 6.556
Authors: Blythe A Corbett; Vanessa Carmean; Susan Ravizza; Carter Wendelken; Melissa L Henry; Cameron Carter; Susan M Rivera Journal: Psychiatry Res Date: 2009-08-08 Impact factor: 3.222
Authors: Celia van der Merwe; Neda Jahanshad; Josh W Cheung; Mary Mufford; Nynke A Groenewold; Nastassja Koen; Rajkumar Ramesar; Shareefa Dalvie; James A Knowles; Derrek P Hibar; Caroline M Nievergelt; Karestan C Koenen; Israel Liberzon; Kerry J Ressler; Sarah E Medland; Rajendra A Morey; Paul M Thompson; Dan J Stein Journal: J Affect Disord Date: 2018-11-13 Impact factor: 4.839
Authors: Andrea L Gold; Elizabeth R Steuber; Lauren K White; Jennifer Pacheco; Jessica F Sachs; David Pagliaccio; Erin Berman; Ellen Leibenluft; Daniel S Pine Journal: Neuropsychopharmacology Date: 2017-04-24 Impact factor: 7.853
Authors: Britta K Hölzel; James Carmody; Karleyton C Evans; Elizabeth A Hoge; Jeffery A Dusek; Lucas Morgan; Roger K Pitman; Sara W Lazar Journal: Soc Cogn Affect Neurosci Date: 2009-09-23 Impact factor: 3.436
Authors: Amy Krain Roy; Roma A Vasa; Maggie Bruck; Karin Mogg; Brendan P Bradley; Michael Sweeney; R Lindsey Bergman; Erin B McClure-Tone; Daniel S Pine Journal: J Am Acad Child Adolesc Psychiatry Date: 2008-10 Impact factor: 8.829